Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells

Katerina Wolf, Elizabeth Fischer, Ted Hackstadt

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Chlamydia pneumoniae is a common human respiratory pathogen that has been associated with a variety of chronic diseases, including atherosclerosis. The role of this organism in the pathogenesis of atherosclerosis remains unknown. A key question is how C. pneumoniae is transferred from the site of primary infection to a developing atherosclerotic plaque. It has been suggested that circulating monocytes could be vehicles for dissemination of C. pneumoniae since the organism has been detected in peripheral blood monocytic cells (PBMCs). In this study we focused on survival of C. pneumoniae within PBMCs isolated from the blood of healthy human donors. We found that C. pneumoniae does not grow and multiply in cultured primary monocytes. In C. pneumoniae-intected monocyte-derived macrophages, growth of the organism was very limited, and the majority of the bacteria were eradicated. We also found that the destruction of C. pneumoniae within infected macrophages resulted in a gradual diminution of chlamydial antigens, although some of these antigens could be detected for days after the initial infection. The detected antigens present in infected monocytes and monocyte-derived macrophages represented neither chlamydial inclusions nor intact organisms. The use of {N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]}-6- aminocaproyl-n-erythro-sphingosine as a vital stain for chlamydiae proved to be a sensitive method for identifying rare C. pneumoniae inclusions and was useful in the detection of even aberrant developmental forms.

Original languageEnglish
Pages (from-to)4560-4570
Number of pages11
JournalInfection and Immunity
Volume73
Issue number8
DOIs
StatePublished - Aug 1 2005

Fingerprint

Chlamydophila pneumoniae
Blood Cells
Monocytes
Macrophages
Antigens
Atherosclerosis
Chlamydia
Atherosclerotic Plaques
Infection
Chronic Disease
Coloring Agents
Bacteria
Survival
Growth

ASJC Scopus subject areas

  • Immunology

Cite this

Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells. / Wolf, Katerina; Fischer, Elizabeth; Hackstadt, Ted.

In: Infection and Immunity, Vol. 73, No. 8, 01.08.2005, p. 4560-4570.

Research output: Contribution to journalArticle

Wolf, Katerina ; Fischer, Elizabeth ; Hackstadt, Ted. / Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells. In: Infection and Immunity. 2005 ; Vol. 73, No. 8. pp. 4560-4570.
@article{d93756e3f0c34c878c48d06174b323cf,
title = "Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells",
abstract = "Chlamydia pneumoniae is a common human respiratory pathogen that has been associated with a variety of chronic diseases, including atherosclerosis. The role of this organism in the pathogenesis of atherosclerosis remains unknown. A key question is how C. pneumoniae is transferred from the site of primary infection to a developing atherosclerotic plaque. It has been suggested that circulating monocytes could be vehicles for dissemination of C. pneumoniae since the organism has been detected in peripheral blood monocytic cells (PBMCs). In this study we focused on survival of C. pneumoniae within PBMCs isolated from the blood of healthy human donors. We found that C. pneumoniae does not grow and multiply in cultured primary monocytes. In C. pneumoniae-intected monocyte-derived macrophages, growth of the organism was very limited, and the majority of the bacteria were eradicated. We also found that the destruction of C. pneumoniae within infected macrophages resulted in a gradual diminution of chlamydial antigens, although some of these antigens could be detected for days after the initial infection. The detected antigens present in infected monocytes and monocyte-derived macrophages represented neither chlamydial inclusions nor intact organisms. The use of {N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]}-6- aminocaproyl-n-erythro-sphingosine as a vital stain for chlamydiae proved to be a sensitive method for identifying rare C. pneumoniae inclusions and was useful in the detection of even aberrant developmental forms.",
author = "Katerina Wolf and Elizabeth Fischer and Ted Hackstadt",
year = "2005",
month = "8",
day = "1",
doi = "10.1128/IAI.73.8.4560-4570.2005",
language = "English",
volume = "73",
pages = "4560--4570",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells

AU - Wolf, Katerina

AU - Fischer, Elizabeth

AU - Hackstadt, Ted

PY - 2005/8/1

Y1 - 2005/8/1

N2 - Chlamydia pneumoniae is a common human respiratory pathogen that has been associated with a variety of chronic diseases, including atherosclerosis. The role of this organism in the pathogenesis of atherosclerosis remains unknown. A key question is how C. pneumoniae is transferred from the site of primary infection to a developing atherosclerotic plaque. It has been suggested that circulating monocytes could be vehicles for dissemination of C. pneumoniae since the organism has been detected in peripheral blood monocytic cells (PBMCs). In this study we focused on survival of C. pneumoniae within PBMCs isolated from the blood of healthy human donors. We found that C. pneumoniae does not grow and multiply in cultured primary monocytes. In C. pneumoniae-intected monocyte-derived macrophages, growth of the organism was very limited, and the majority of the bacteria were eradicated. We also found that the destruction of C. pneumoniae within infected macrophages resulted in a gradual diminution of chlamydial antigens, although some of these antigens could be detected for days after the initial infection. The detected antigens present in infected monocytes and monocyte-derived macrophages represented neither chlamydial inclusions nor intact organisms. The use of {N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]}-6- aminocaproyl-n-erythro-sphingosine as a vital stain for chlamydiae proved to be a sensitive method for identifying rare C. pneumoniae inclusions and was useful in the detection of even aberrant developmental forms.

AB - Chlamydia pneumoniae is a common human respiratory pathogen that has been associated with a variety of chronic diseases, including atherosclerosis. The role of this organism in the pathogenesis of atherosclerosis remains unknown. A key question is how C. pneumoniae is transferred from the site of primary infection to a developing atherosclerotic plaque. It has been suggested that circulating monocytes could be vehicles for dissemination of C. pneumoniae since the organism has been detected in peripheral blood monocytic cells (PBMCs). In this study we focused on survival of C. pneumoniae within PBMCs isolated from the blood of healthy human donors. We found that C. pneumoniae does not grow and multiply in cultured primary monocytes. In C. pneumoniae-intected monocyte-derived macrophages, growth of the organism was very limited, and the majority of the bacteria were eradicated. We also found that the destruction of C. pneumoniae within infected macrophages resulted in a gradual diminution of chlamydial antigens, although some of these antigens could be detected for days after the initial infection. The detected antigens present in infected monocytes and monocyte-derived macrophages represented neither chlamydial inclusions nor intact organisms. The use of {N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]}-6- aminocaproyl-n-erythro-sphingosine as a vital stain for chlamydiae proved to be a sensitive method for identifying rare C. pneumoniae inclusions and was useful in the detection of even aberrant developmental forms.

UR - http://www.scopus.com/inward/record.url?scp=23344432885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23344432885&partnerID=8YFLogxK

U2 - 10.1128/IAI.73.8.4560-4570.2005

DO - 10.1128/IAI.73.8.4560-4570.2005

M3 - Article

C2 - 16040967

AN - SCOPUS:23344432885

VL - 73

SP - 4560

EP - 4570

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 8

ER -